YTHDF1和WTAP基因在丽水市结直肠癌中的m6A甲基化修饰对肿瘤分化的影响研究
Investigation of the Impact of m6A Methylation Modifications of YTHDF1 and WTAP Genes on Tumor Differentiation in Colorectal Cancer in Lishui City
DOI: 10.12677/acm.2025.154969, PDF,    科研立项经费支持
作者: 吴 珺, 廖旭慧, 毛新武, 潘莉妃:丽水市人民医院病理科,浙江 丽水;张 强:丽水市人民医院检验科,浙江 丽水;杨 浩*:浙江省人民医院(杭州医学院附属人民医院)临床研究中心,浙江 杭州
关键词: 丽水市m6A结直肠癌癌症分化YTHDF1WTAPTTP OSLishui City m6A Colorectal Cancer Differentiation YTHDF1 WTAP TTP OS
摘要: 目的:目前尚不清楚m6A甲基化基因在结直肠癌分化中的作用。本研究结合生物信息学分析与实验验证,探讨这些基因在结直肠癌中的表达特征及其潜在机制。方法:利用生物信息学,我们发现YTHDF1、YTHDF2、ALKBH5、WTAP与结直肠癌表达异常显著(p < 0.05)。在现实世界中,我们使用定量PCR (Q-PCR)来测量这四个基因在丽水地区结直肠癌及癌旁中的mRNA表达。应用SPSS软件进行多变量逻辑回归分析,我们发现这YTHDF1和WTAP基因mRNA表达水平与结直肠癌分化进程相关。通过免疫组化,我们检查了相应的蛋白表达,并使用Image J进行量化,结果显示,YTHDF1蛋白的表达水平与结直肠癌分化进程呈显著负相关;WTAP蛋白表达水平与结直肠癌分化进程呈显著正相关。此外,我们进行了多变量Cox回归分析,以识别与结直肠癌发生相关的潜在影响因素。结果:在中国丽水地区,YTHDF1蛋白表达与结直肠癌的分化水平呈负相关;WTAP的蛋白表达与结直肠癌的分化水平呈正相关。年龄和饮酒史是结直肠癌发病的关键因素,与性别吸烟无显著关联。GO富集分析表明,YTHDF1和WTAP可能通过参与mRNA修饰、翻译调控和RNA稳定性等机制,进而调控结直肠癌的分化过程。此外,三年内低分化组观察到疾病进展率(TTP)100%和总生存期率(OS)达到0%。结论:在丽水市,YTHDF1和WTAP蛋白影响结直肠癌分化,可能是结直肠癌患者的重要治疗靶点和生物诊断标志物。
Abstract: Background: The role of m6A methylation genes in the differentiation of colorectal cancer is currently unclear. This study combines bioinformatics analysis and experimental validation to explore the expression patterns of these genes in colorectal cancer and their potential mechanisms. Methods: Using bioinformatics, we found that YTHDF1, YTHDF2, ALKBH5, and WTAP are significantly aberrantly expressed in colorectal cancer (p < 0.05). In a real-world cohort from Lishui, quantitative PCR (qPCR) was used to measure mRNA expression of these four genes in CRC tissues and adjacent normal tissues. Multivariable logistic regression analysis with SPSS identified YTHDF1 and WTAP mRNA expression levels as being associated with CRC differentiation. Immunohistochemistry (IHC) was performed to examine corresponding protein levels, quantified using ImageJ. Results showed that YTHDF1 protein expression negatively correlated with CRC differentiation, whereas WTAP protein expression positively correlated. Additionally, multivariable Cox regression analysis was conducted to identify potential factors influencing CRC development. Results: In Lishui, YTHDF1 protein expression was negatively associated with CRC differentiation, while WTAP protein expression was positively associated. Age and alcohol consumption were key risk factors for CRC development, while no significant associations were found with sex or smoking. GO enrichment analysis suggests that YTHDF1 and WTAP may regulate the differentiation process of colorectal cancer by participating in mechanisms such as mRNA modification, translation regulation, and RNA stability. For the poorly differentiated CRC group, time to progression rate (TTP) was 100% and overall survival rate (OS) was 0% within three years. Conclusions: In Lishui City, the YTHDF1 and WTAP genes influence the differentiation of colorectal cancer and may serve as important therapeutic targets and biomarkers for the diagnosis of patients with colorectal cancer.
文章引用:吴珺, 廖旭慧, 毛新武, 潘莉妃, 张强, 杨浩. YTHDF1和WTAP基因在丽水市结直肠癌中的m6A甲基化修饰对肿瘤分化的影响研究[J]. 临床医学进展, 2025, 15(4): 571-582. https://doi.org/10.12677/acm.2025.154969

参考文献

[1] Obafemi, F.A. and Umahi-Ottah G. (2023) A Review of Global Cancer Prevalence and Therapy. Journal of Cancer Research, Treatment & Prevention, 1, 128-147. [Google Scholar] [CrossRef
[2] Li, J., Han, Y., Zhou, M., Liu, N., Li, H., Huang, G., et al. (2023) Electroacupuncture Ameliorates AOM/DSS-Induced Mice Colorectal Cancer by Inhibiting Inflammation and Promoting Autophagy via the SIRT1/miR-215/Atg14 Axis. Aging, 15, 13194-13212. [Google Scholar] [CrossRef] [PubMed]
[3] Brown, I., Zammit, A.P., Bettington, M., Cooper, C., Gill, A.J., Agoston, A., et al. (2023) Pathological Features Associated with Metastasis in Patients with Early Invasive (pT1) Colorectal Carcinoma in Colorectal Polyps. Histopathology, 83, 591-606. [Google Scholar] [CrossRef] [PubMed]
[4] Baretti, M. and Le, D.T. (2018) DNA Mismatch Repair in Cancer. Pharmacology & Therapeutics, 189, 45-62. [Google Scholar] [CrossRef] [PubMed]
[5] Heregger, R., Huemer, F., Steiner, M., Gonzalez-Martinez, A., Greil, R. and Weiss, L. (2023) Unraveling Resistance to Immunotherapy in MSI-High Colorectal Cancer. Cancers, 15, Article 5090. [Google Scholar] [CrossRef] [PubMed]
[6] Sakshaug, B.C., Folkesson, E., Haukaas, T.H., Visnes, T. and Flobak, Å. (2023) Systematic Review: Predictive Value of Organoids in Colorectal Cancer. Scientific Reports, 13, Article No. 18124. [Google Scholar] [CrossRef] [PubMed]
[7] Zeng, J., Fan, W., Li, J., Wu, G. and Wu, H. (2023) KRAS/NRAS Mutations Associated with Distant Metastasis and BRAF/PIK3CA Mutations Associated with Poor Tumor Differentiation in Colorectal Cancer. International Journal of General Medicine, 16, 4109-4120. [Google Scholar] [CrossRef] [PubMed]
[8] Lim, S., Joe, S., Kim, H., Lee, J.L., Park, I.J., Yoon, Y.S., et al. (2023) Deciphering the DNA Methylation Landscape of Colorectal Cancer in a Korean Cohort. BMB Reports, 56, 569-574. [Google Scholar] [CrossRef] [PubMed]
[9] Ciobanu, A.E., Pîrvu, D., Mărginean, C.M., Dijmărescu, A.L., Muñoz-Groza, A., Meşină, C., et al. (2023) Molecular Prognostic Factors in Colorectal Cancer: 5-Year Follow-up. Romanian Journal of Morphology and Embryology, 64, 65-71. [Google Scholar] [CrossRef] [PubMed]
[10] Sell, T., Klotz, C., Fischer, M.M., Astaburuaga-García, R., Krug, S., Drost, J., et al. (2023) Oncogenic Signaling Is Coupled to Colorectal Cancer Cell Differentiation State. Journal of Cell Biology, 222, e202204001. [Google Scholar] [CrossRef] [PubMed]
[11] Mirzapoor Abbasabadi, Z., Hamedi Asl, D., Rahmani, B., Shahbadori, R., Karami, S., Peymani, A., et al. (2023) KRAS, NRAS, BRAF, and PIK3CA Mutation Rates, Clinicopathological Association, and Their Prognostic Value in Iranian Colorectal Cancer Patients. Journal of Clinical Laboratory Analysis, 37, e24868. [Google Scholar] [CrossRef] [PubMed]
[12] Wen, T., Li, T., Xu, Y., Zhang, Y., Pan, H. and Wang, Y. (2023) The Role of M6a Epigenetic Modifications in Tumor Coding and Non-Coding RNA Processing. Cell Communication and Signaling, 21, Article No. 355. [Google Scholar] [CrossRef] [PubMed]
[13] Shen, L. (2023) Functional Interdependence of N6-Methyladenosine Methyltransferase Complex Subunits in Arabidopsis. The Plant Cell, 35, 1901-1916. [Google Scholar] [CrossRef] [PubMed]
[14] Lin, Y., Shi, H., Wu, L., Ge, L. and Ma, Z. (2023) Research Progress of N6-Methyladenosine in Colorectal Cancer: A Review. Medicine, 102, e36394. [Google Scholar] [CrossRef] [PubMed]
[15] Hu, R., Cao, Y., Wang, Y., Zhao, T., Yang, K., Fan, M., et al. (2024) TMEM120B Strengthens Breast Cancer Cell Stemness and Accelerates Chemotherapy Resistance via β1-Integrin/FAK-TAZ-mTOR Signaling Axis by Binding to MYH9. Breast Cancer Research, 26, Article No. 48. [Google Scholar] [CrossRef] [PubMed]
[16] Tang, W., Kong, X., He, S., Deng, J., Mao, M., Peng, S., et al. (2024) WTAP Regulates SOX1 Expression to Affect the Tumorigenicity of Colorectal Cancer via an m6A-YTHDF2-Dependent Manner. Digestive Diseases and Sciences, 70, 598-611. [Google Scholar] [CrossRef] [PubMed]
[17] Zou, Z. and He, C. (2024) The YTHDF Proteins Display Distinct Cellular Functions on m6A-Modified RNA. Trends in Biochemical Sciences, 49, 611-621. [Google Scholar] [CrossRef] [PubMed]
[18] Liu, W., Zheng, S., Li, T., Fei, Y., Wang, C., Zhang, S., et al. (2024) RNA Modifications in Cellular Metabolism: Implications for Metabolism-Targeted Therapy and Immunotherapy. Signal Transduction and Targeted Therapy, 9, Article No. 70. [Google Scholar] [CrossRef] [PubMed]
[19] Chen, J., Zhang, I.L., Terry, M.B. and Yang, W. (2022) Dietary Factors and Early-Onset Colorectal Cancer in the United States—An Ecologic Analysis. Cancer Epidemiology, Biomarkers & Prevention, 32, 217-225. [Google Scholar] [CrossRef] [PubMed]
[20] Obeagu, E.I. and Obeagu, G.U. (2024) Breast Cancer: A Review of Risk Factors and Diagnosis. Medicine, 103, e36905. [Google Scholar] [CrossRef] [PubMed]
[21] Ferreira, M.L., De Luca, K., Haile, L.M., et al. (2023) Global, Regional, and National Burden of Low Back Pain, 1990-2020, Its Attributable Risk Factors, and Projections to 2050: A Systematic Analysis of the Global Burden of Disease Study 2021. The Lancet Rheumatology, 5, e316-e329.